Form 8-K - Current report:
SEC Accession No. 0001746473-26-000107
Filing Date
2026-07-13
Accepted
2026-07-13 16:25:14
Documents
12
Period of Report
2026-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K plrx-20260709.htm   iXBRL 8-K 30456
  Complete submission text file 0001746473-26-000107.txt   193493

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20260709.xsd EX-101.SCH 2914
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20260709_def.xml EX-101.DEF 16530
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20260709_lab.xml EX-101.LAB 29957
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20260709_pre.xml EX-101.PRE 17328
15 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20260709_htm.xml XML 4151
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 261171581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)